Inés Gómez‐Seguí

2.6k total citations
60 papers, 603 citations indexed

About

Inés Gómez‐Seguí is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Inés Gómez‐Seguí has authored 60 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 18 papers in Immunology and 12 papers in Genetics. Recurrent topics in Inés Gómez‐Seguí's work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (13 papers) and Complement system in diseases (11 papers). Inés Gómez‐Seguí is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (13 papers) and Complement system in diseases (11 papers). Inés Gómez‐Seguí collaborates with scholars based in Spain, United States and Japan. Inés Gómez‐Seguí's co-authors include Javier de la Rubia, António Pellicer, Anna Buigues, César Díaz‐García, Mónica Romeu, Sonia Herraiz, Pilar Solves, Miguel Á. Sanz, Guillermo Sanz and Pau Montesinos and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Inés Gómez‐Seguí

48 papers receiving 598 citations

Peers

Countries citing papers authored by Inés Gómez‐Seguí

Since Specialization

Citations

This map shows the geographic impact of Inés Gómez‐Seguí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inés Gómez‐Seguí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inés Gómez‐Seguí more than expected).

Fields of papers citing papers by Inés Gómez‐Seguí

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inés Gómez‐Seguí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inés Gómez‐Seguí. The network helps show where Inés Gómez‐Seguí may publish in the future.

Co-authorship network of co-authors of Inés Gómez‐Seguí

This figure shows the co-authorship network connecting the top 25 collaborators of Inés Gómez‐Seguí. A scholar is included among the top collaborators of Inés Gómez‐Seguí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inés Gómez‐Seguí. Inés Gómez‐Seguí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura 2025 ·Frontiers in Immunology ·(unknown), María Queralt Salas, Cristina Pascual, Mercedes Villalobos, Inés Gómez‐Seguí, (unknown), (unknown), Jorge Martínez Nieto, (unknown), Miquel Lozano, Joan Cid, (unknown), (unknown), Patricia Molina, (unknown), (unknown), Ana Belén Moreno‐Castaño, Julia Martínez-Sánchez, Ginés Escolar, (unknown)	0
2	Rare onset of congenital thrombotic thrombocytopenic purpura during pregnancy: A novel ADAMTS13 gene variant 2025 ·Transfusion ·(unknown), (unknown), Inés Gómez‐Seguí, Jorge Martínez Nieto, (unknown), (unknown), (unknown)	0
3	Patient Blood Management in Hematology: Focusing on Platelet Transfusion 2025 ·Journal of Clinical Medicine ·Pilar Solves, (unknown), (unknown), Bruno Lamas, David Martı́nez, (unknown), Inés Gómez‐Seguí, Javier de la Rubia	0
4	Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide 2025 ·Transplantation and Cellular Therapy ·(unknown), (unknown), (unknown), Aitana Balaguer‐Roselló, Juan Montoro, (unknown), Eva González, María Dolores Gómez‐Roig, Inés Gómez‐Seguí, Pilar Solves, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Miguel Salavert, Javier de la Rubia, Miguel Á. Sanz, Jaime Sanz	0
5	Frequency and Distribution of KIR Genotypes of Donors‐Recipient Pairs in the Haploidentical Haematopoietic Stem Cell Transplantation Setting: Collaborative Study by the Spanish Working Group in Histocompatibility and Transplant Immunology (GETHIT) and the Spanish Haematopoietic Transplantation and Cell Therapy Group (GETH‐TC) 2025 ·HLA ·(unknown), Dolores Planelles, José Luís Piñana, Juan Antonio Carbonell‐Asins, Paula Amat, Inés Gómez‐Seguí, Manuel Guerreiro, Abelardo Caballero, Alberto Torı́o, (unknown), Francisco Boix, Luis Marı́n, Lourdes Vázquez, Natalia Martínez‐Pomar, (unknown), Antònia Sampol, J. L. Ochoa, Cristina Arbona, Carlos Solano	0
6	Single-Unit Transfusion Policy in Autologous Hematopoietic Stem Cell Transplantation: Less is Not Worse 2024 ·Transfusion Medicine Reviews ·Javier Marco, (unknown), (unknown), (unknown), (unknown), Inés Gómez‐Seguí, (unknown), Jaime Sanz, (unknown), Miguel Á. Sanz, Javier de la Rubia, Pilar Solves	0
7	Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience 2024 ·Bone Marrow Transplantation ·Miguel Á. Sanz, Juan Montoro, Aitana Balaguer‐Roselló, (unknown), (unknown), Inés Gómez‐Seguí, Pilar Solves, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David Martı́nez, (unknown), (unknown), (unknown), (unknown), Javier de la Rubia, Jaime Sanz	4
8	Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons 2024 ·Expert Review of Hematology ·Inés Gómez‐Seguí, María Eva Mingot‐Castellano, Cristina Pascual, Javier de la Rubia	2
9	Effect of autologous umbilical cord blood transfusion in the development of retinopathy of prematurity: randomized clinical trial – study protocol 2023 ·Frontiers in Pediatrics ·(unknown), (unknown), (unknown), (unknown), (unknown), María Cernada, Julia Kuligowski, (unknown), Inés Gómez‐Seguí, Máximo Vento, Marta Aguar	5
10	T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia 2023 ·Transplantation and Cellular Therapy ·(unknown), Juan Montoro, Aitana Balaguer‐Roselló, Manuel Guerreiro, (unknown), (unknown), Pilar Solves, Inés Gómez‐Seguí, Marcelo C. Pasquini, (unknown), (unknown), (unknown), Javier de la Rubia, Miguel Á. Sanz, Jaime Sanz	1
11	Extracorporeal Photopheresis in Graft-versus-Host Disease 2023 ·Transplantation and Cellular Therapy ·(unknown), Jaime Sanz, Pilar Solves, Javier de la Rubia, Inés Gómez‐Seguí	9
12	Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT) 2023 ·British Journal of Haematology ·Inés Gómez‐Seguí, (unknown), María Eva Mingot‐Castellano, (unknown), (unknown), (unknown), (unknown), Julio del Río-Garma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), José María García‐Gala, (unknown), Jorge Martínez Nieto, (unknown), (unknown), (unknown), (unknown), Luís Hernández, Joan Cid, Javier de la Rubia, (unknown)	3
13	Reduced Incidence of Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Calcineurin-Free Graft-versus-Host Disease Prophylaxis 2023 ·Transplantation and Cellular Therapy ·Aitana Balaguer‐Roselló, Sara Gil‐Perotín, Juan Montoro, Luís Bataller, (unknown), (unknown), (unknown), Manuel Guerreiro, (unknown), (unknown), (unknown), Inés Gómez‐Seguí, Pilar Solves, (unknown), Javier de la Rubia, Miguel Á. Sanz, Jaime Sanz	0
14	Impact of Post-Transplantation Cyclophosphamide on Transfusion Requirements in HLA-Matched Sibling Peripheral Blood Stem Cell Transplantation 2023 ·Transplantation and Cellular Therapy ·Javier Marco, Jaime Sanz, Inés Gómez‐Seguí, Aitana Balaguer‐Roselló, Juan Montoro, Manuel Guerreiro, (unknown), (unknown), (unknown), Miguel Á. Sanz, Javier de la Rubia, Pilar Solves	9
15	Real-World Experience in Extracorporeal Photopheresis for Adults with Graft-versus-Host Disease 2023 ·Transplantation and Cellular Therapy ·(unknown), Jaime Sanz, (unknown), (unknown), (unknown), (unknown), Ana Malvar, (unknown), Manuel Guerreiro, Aitana Balaguer‐Roselló, Juan Montoro, (unknown), (unknown), Miguel Á. Sanz, (unknown), Inés Gómez‐Seguí	3
16	Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution 2023 ·Journal of Clinical Medicine ·Pilar Solves, Javier Marco, Miguel Á. Sanz, Inés Gómez‐Seguí, Aitana Balaguer‐Roselló, (unknown), (unknown), Juan Montoro, Guillermo Sanz, Javier de la Rubia, Jaime Sanz	1
17	An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura 2022 ·Expert Review of Hematology ·Inés Gómez‐Seguí, Cristina Pascual, María Eva Mingot‐Castellano, Javier de la Rubia	6
18	Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question 2020 ·Bone Marrow Transplantation ·Javier Marco, Inés Gómez‐Seguí, Guillermo Sanz, Pilar Solves	24
19	The modular network structure of the mutational landscape of Acute Myeloid Leukemia 2018 ·PLoS ONE ·Mariam Ibáñez, José Carbonell‐Caballero, Esperanza Such, Luz García‐Alonso, Alessandro Liquori, Maria López‐Pavía, Marta Llop, Carmen Alonso, Eva Barragán, Inés Gómez‐Seguí, Alexander Neef, David Hervás, Pau Montesinos, Guillermo Sanz, Miguel Á. Sanz, Joaquı́n Dopazo, José Cervera	5
20	Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patients 2012 ·Annals of Hematology ·Irene Luna, Esperanza Such, José Cervera, Eva Barragán, Antonio Jiménez‐Velasco, (unknown), Mariam Ibáñez, Inés Gómez‐Seguí, Maria López‐Pavía, Marta Llop, Óscar Fuster, Silvestre Oltra, Federico Moscardó, David Martínez‐Cuadrón, (unknown), (unknown), Pau Montesinos, Guillermo Martı́n, Pascual Bolufer, Miguel Á. Sanz	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact